The stimulus for the development of mixed agonist-antagonist drugs stemmed from the desire to have pain relievers like opiods with less respiratory depression and addictive potential.

TALLAHASSEE (CBSMiami/NSF) - House and Senate committees this week backed proposals aimed at helping stop potential drug overdoses. The proposals (HB 751 and SB 758) would allow prescriptions to ...

Going under general anesthesia is not an effective way for heroin users to avoid the painful, drawn-out process of breaking their habit and can be dangerous, a study said on Tuesday.

- February 17, 2021 DUBLIN– (BUSINESS WIRE)–Feb 16, 2021– The "LAG-3 Antagonist – Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com’s offering.

Contineum: LPA1R Antagonist Drug Advancement Against IPF With Proven Track Model Jun. 13, 2024 2:03 PM ET Contineum Therapeutics, Inc. (CTNM) Stock BMY, AMGN, ABBV JNJ ABBV:CA BMYMP CELG.RT JNJ:CA ...

Data Establish ChemoCentryx Drug as the First True Orally-Active Small Molecule C5aR InhibitorMOUNTAIN VIEW, Calif., Nov. 10, 2010 /PRNewswire/ -- ChemoCentryx, Inc., today announced favorable Phase ...